Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer

This study has been terminated.
(Slow accrual)
Sponsor:
Collaborator:
Ortho Biotech, Inc.
Information provided by:
University of Kentucky
ClinicalTrials.gov Identifier:
NCT00176293
First received: September 13, 2005
Last updated: January 7, 2008
Last verified: January 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2007
  Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)